Table 1.
Health endpoint | PDF of concentration–response coefficient (β) |
Reference of β (age group) |
Annual estimates (95% Confidence interval) |
---|---|---|---|
Mortality | |||
Adult all-cause | Normal (0.005827, 0.000963) | Krewski et al. (2009) (age ≥30) | 13,910 (9419–18,391) |
Normal (0.05827, 0.009524) | Janssen et al. (2011) (age ≥30) | 133,807 (92,259–174,523) | |
Uniform (0.005827, 0.05827) | Krewski et al. (2009) & | 74,689 (17,026–131,050) | |
Triangular (0.005827, 0.05827) | Janssen et al. (2011) (age ≥30) | 74,882 (27,791–120,969) | |
Infant | Normal (0.006766, 0.007339) | Woodruff et al. (1997) (age b1) | 32 (13–52) |
Morbidity | |||
Hospital admissions – all respiratory | Normal (0.00207, 0.0004464) | Zanobetti et al. (2009) (age N64) | 3380 (1952–4805) |
Hospital admissions – all cardiovascular | Normal (0.00189, 0.0002832) | Zanobetti et al. (2009) (age N64) | 4344 (3070–5618) |
Emergency room visits for asthma | Normal (0.0056, 0.0021) | Mar et al. (2010) (all ages) | 10,567 (2804–18,290) |
Acute bronchitis | Normal (0.02721, 0.017) | Dockery et al. (1996) (ages 8–12) | 20,913 (−4983–45,928) |
Chronic bronchitis | Normal (0.0137, 0.006796) | Abbey et al. (1994) (age N27) | 9604 (269–18,799) |
Lower respiratory symptoms | Normal (0.019, 0.006) | Schwartz and Neas (2000) (ages 7–14) | 269,180 (103,588–432,608) |
Upper respiratory symptoms | Normal (0.0036, 0.0015) | Pope III et al. (1991) (ages 9–11) | 389,951 (71,557–708,006) |
Asthma exacerbation Cough | Normal (0.00099, 0.00075) | Ostro et al. (2001) (ages 6–18) | 253,806 (−123,529–630,696) |
Shortness of breath | Normal (0.0026, 0.0013) | 364,800 (−7312–735,972) | |
Wheeze | Normal (0.0019, 0.0008) | 577,220 (109,712–1,044,186) | |
Work loss days | Normal (0.0046, 0.00036) | Ostro (1987) (ages 18–64) | 1,910,323 (1,618,200–2,202,217) |
Minor restricted-activity days | Normal (0.007410, 0.000700) | Ostro and Rothschild (1989) (ages 18–64) | 11,332,839 (9,244,613–13,417,870) |